Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition

被引:16
作者
Galbraith, Matthew D. [1 ,2 ]
Rachubinski, Angela L. [1 ,3 ]
Smith, Keith P. [1 ]
Araya, Paula [1 ]
Waugh, Katherine A. [1 ,2 ]
Enriquez-Estrada, Belinda [1 ]
Worek, Kayleigh [1 ]
Granrath, Ross E. [1 ]
Kinning, Kohl T. [1 ]
Eduthan, Neetha Paul [1 ]
Ludwig, Michael P. [1 ]
Hsieh, Elena W. Y. [4 ,5 ]
Sullivan, Kelly D. [1 ,6 ]
Espinosa, Joaquin M. [1 ,2 ]
机构
[1] Univ Colorado, Linda Crn Inst Syndrome, Anschutz Med Campus, Aurora, CO 80309 USA
[2] Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80309 USA
[3] Univ Colorado, Dept Pediat, Sect Dev Pediat, Anschutz Med Campus, Aurora, CO USA
[4] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA
[5] Univ Colorado, Dept Pediat, Div Allergy Immunol, Anschutz Med Campus, Aurora, CO USA
[6] Univ Colorado, Dept Pediat, Sect Dev Biol, Anschutz Med Campus, Aurora, CO USA
关键词
I-INTERFERON; IMMUNE; EXPRESSION; METABOLISM; PREGNANCY; MODELS; GROWTH;
D O I
10.1126/sciadv.adg6218
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Individuals with Down syndrome (DS) display chronic hyperactivation of interferon signaling. However, the clinical impacts of interferon hyperactivity in DS are ill-defined. Here, we describe a multiomics investigation of interferon signaling in hundreds of individuals with DS. Using interferon scores derived from the whole blood transcriptome, we defined the proteomic, immune, metabolic, and clinical features associated with interferon hyperactivity in DS. Interferon hyperactivity associates with a distinct proinflammatory phenotype and dysregulation of major growth signaling and morphogenic pathways. Individuals with the highest interferon activity display the strongest remodeling of the peripheral immune system, including increased cytotoxic T cells, B cell depletion, and monocyte activation. Interferon hyperactivity accompanies key metabolic changes, most prominently dysregulated tryptophan catabolism. High interferon signaling stratifies a subpopulation with elevated rates of congenital heart disease and autoimmunity. Last, a longitudinal case study demonstrated that JAK inhibition normalizes interferon signatures with therapeutic benefit in DS. Together, these results justify the testing of immune-modulatory therapies in DS.
引用
收藏
页数:22
相关论文
共 80 条
  • [1] [Anonymous], 2023, NAT GENET, V55, P1034, DOI [10.1038/s41588-023-01399-7, DOI 10.1038/S41588-023-01399-7]
  • [2] [Anonymous], 2022, RStudio
  • [3] Down syndrome
    Antonarakis, Stylianos E.
    Skotko, Brian G.
    Rafii, Michael S.
    Strydom, Andre
    Pape, Sarah E.
    Bianchi, Diana W.
    Sherman, Stephanie L.
    Reeves, Roger H.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [4] IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome
    Araya, Paula
    Kinning, Kohl T.
    Coughlan, Christina
    Smith, Keith P.
    Granrath, Ross E.
    Enriquez-Estrada, Belinda A.
    Worek, Kayleigh
    Sullivan, Kelly D.
    Rachubinski, Angela L.
    Wolter-Warmerdam, Kristine
    Hickey, Francis
    Galbraith, Matthew D.
    Potter, Huntington
    Espinosa, Joaquin M.
    [J]. CELL REPORTS, 2022, 41 (13):
  • [5] Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity
    Araya, Paula
    Waugh, Katherine A.
    Sullivan, Kelly D.
    Nunez, Nicolas G.
    Roselli, Emiliano
    Smith, Keith P.
    Granrath, Ross E.
    Rachubinski, Angela L.
    Estrada, Belinda Enriquez
    Butcher, Eric T.
    Minter, Ross
    Tuttle, Kathryn D.
    Bruno, Tullia C.
    Maccioni, Mariana
    Espinosa, Joaquin M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (48) : 24231 - 24241
  • [6] Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome
    Aziz, Nadine M.
    Guedj, Faycal
    Pennings, Jeroen L. A.
    Olmos-Serrano, Jose Luis
    Siegel, Ashley
    Haydar, Tarik F.
    Bianchi, Diana W.
    [J]. DISEASE MODELS & MECHANISMS, 2018, 11 (06)
  • [7] Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes
    Balistreri, Carmela Rita
    Ammoscato, Claudia Leonarda
    Scola, Letizia
    Fragapane, Tiziana
    Giarratana, Rosa Maria
    Lio, Domenico
    Piccione, Maria
    [J]. GENES, 2020, 11 (12) : 1 - 13
  • [8] Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
    Banchereau, Romain
    Hong, Seunghee
    Cantarel, Brandi
    Baldwin, Nicole
    Baisch, Jeanine
    Edens, Michelle
    Cepika, Alma-Martina
    Acs, Peter
    Turner, Jacob
    Anguiano, Esperanza
    Vinod, Parvathi
    Kahn, Shaheen
    Obermoser, Gerlinde
    Blankenship, Derek
    Wakeland, Edward
    Nassi, Lorien
    Gotte, Alisa
    Punaro, Marilynn
    Liu, Yong-Jun
    Banchereau, Jacques
    Rossello-Urgell, Jose
    Wright, Tracey
    Pascual, Virginia
    [J]. CELL, 2016, 165 (03) : 551 - 565
  • [9] METABOLISM OF TRYPTOPHAN .2. METABOLISM OF TRYPTOPHAN IN PATIENTS SUFFERING FROM CANCER OF THE BLADDER
    BOYLAND, E
    WILLIAMS, DC
    [J]. BIOCHEMICAL JOURNAL, 1956, 64 (03) : 578 - 582
  • [10] Health Supervision for Children and Adolescents With Down Syndrome
    Bull, Marilyn J.
    Trotter, Tracy
    Santoro, Stephanie L.
    Christensen, Celanie
    Grout, Randall W.
    [J]. PEDIATRICS, 2022, 149 (05)